Theseus Pharmaceuticals Cash Flow Statement

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2011	FY 2010	2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	2020
Net Income	58,546	126,147	63,202	-317,882	-	-	Upgrade
Depreciation & Amortization, Total	325.5	263.1	1,170	1,481	-	-	Upgrade
Gain (Loss) On Sale of Investments	28,737	67,764	-84,459	7,394	-	-	Upgrade
Change in Accounts Receivable	218.23	-80.89	19.46	465.27	-	-	Upgrade
Change in Other Net Operating Assets	-16,797	17,887	558,654	143,762	-	-	Upgrade
Other Operating Activities	-32,761	-17,542	6,531	346,888	-	-	Upgrade
Operating Cash Flow	113,843	386,504	205,896	214,807	-	-	Upgrade
Capital Expenditures	-1,745	-	-	-159.79	-	-	Upgrade
Other Investing Activities	2,203	2,430	1,119	1,065	-	-	Upgrade
Investing Cash Flow	458	2,430	1,166	905.52	-	-	Upgrade
Short-Term Debt Issued	-	-	-	5,656,755	-	-	Upgrade
Total Debt Issued	-	-	-	5,656,755	-	-	Upgrade
Short-Term Debt Repaid	-	-	-114,480	-5,811,760	-	-	Upgrade
Total Debt Repaid	-	-	-114,480	-5,811,760	-	-	Upgrade
Net Debt Issued (Repaid)	-	-	-114,480	-155,005	-	-	Upgrade
Issuance of Common Stock	-	-	-	1,170	-	-	Upgrade
Common Dividends Paid	-	-	-	-111,259	-	-	Upgrade
Financing Cash Flow	-	-	-114,480	-265,094	-	-	Upgrade
Net Cash Flow	114,301	388,934	92,582	-49,382	-	-	Upgrade
Free Cash Flow	112,098	386,504	205,896	214,647	-	-	Upgrade
Free Cash Flow Growth	-66.77%	87.72%	-4.08%	-	-	-	Upgrade
Free Cash Flow Margin	127.95%	232.33%	147.77%	157.77%	-	-	Upgrade
Free Cash Flow Per Share	1000.01	3447.94	1837.47	1915.66	-	-	Upgrade
Cash Interest Paid	-	-	6,995	-	-	-	Upgrade
Cash Income Tax Paid	1,200	1,200	1,382	-	-	-	Upgrade

Updated Jan 22, 2025. Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.